Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Code of Conduct for Prevention of Insider Trading of the Company, Fredun Pharmaceuticals has informed that the Trading Window for dealing in the securities of the Company will remain closed for Designated Persons and their immediate relatives with effect from Wednesday, January 1, 2019 till 48 hours after the end of the Board Meeting wherein; the approval of the Un-Audited Financial Results for the Quarter and Nine months ended December 31, 2019; would be considered, approved and declared. The date of the Board Meeting for considering and approval of the Un-Audited Financial Results of the Company for the Quarter and Nine months ended December 31, 2019 shall be informed in the due course. The said information is being notified to all Designated Persons under the above Regulations.
The above information is a part of company's filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: